AzTrials
AzTrials

Proximal Humeral FractureNCT03243409

Perioperative Complications in Reversed Shoulder Arthroplasties

An observational study of Proximal Humeral Fracture, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Retrospective observational study of reversed shoulder arthroplasties by proximal humeral fracture. Analysis of preoperative risk factors as well as minor and major complications at the first week, 90 days and 1 year. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Proximal Humeral Fracture
How many people
105 participants
Where
1 siteSpain
Study dates
25 Jul 2017to 31 Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Older adult

Study population: Patients undergoing reversed shoulder arthroplasties owing to three or four parts fractures of the proximal humerus

Who may be able to join

  • Complex( 3- or 4-part) humerus fractures undergoing reversed shoulder arthroplasties.

Who cannot join

  • No exclusion criteria

Trial locations and contacts

1 site in 1 country.

Laura Noguera Alonso contact

+34660708399

lnoguera@santpau.cat

Spain1 site, 1 recruiting
  • Hospital de la Santa Creu i Sant Pau

    Barcelona, 08025

    Laura Noguera, MD, lnoguera@santpau.cat

    Recruiting

Other trials in Spain

About this study

Official title: Perioperative Complications in Proximal Humeral Fractures Treated With Reversed Shoulder Arthroplasties

Retrospective observational study of reversed shoulder arthroplasties by proximal humeral fracture. Analysis of preoperative risk factors as well as minor and major complications at the first week, 90 days and 1 year.

Read the detailed description

The study is a multicenter retrospective observational study (3 centers). Data are collected from 105 patients over 65 years-old undergoing reversed shoulder arthroplasties by proximal humerus fractures, in 3 or 4 parts.

Patient information is obtained from the clinical records in their usual preoperative assessment, and follow-up on the usual routine checks, at the first week, 90 days and 1 year.

Minor and major complications rates are evaluated according to preoperative risk (ASA), underlying diseases and according to anticoagulant / antiaggregant treatments.

Likewise, transfusion rates related to ASA, as well as length of hospital stay related to it.

Keywords
reversed shoulder arthroplasties, clinical complications, complex proximal humeral fractures
Medical subject headings
Shoulder Fractures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties

    Measured: First week after surgery

  2. Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties

    Measured: 90 days after surgery

  3. Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Minor complications are medical complications, which usually don't affect to the functional outcome of arthroplasties

    Measured: 1 year after surgery

  4. Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery

    Measured: First week after surgery

  5. Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery

    Measured: 90 days after surgery

  6. Number of patients affected by major complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures.

    Major complications are surgical complications( dislocation, periprosthetic fracture, infection) which usually affect to the functional outcome and can lead to a revision surgery

    Measured: 1 year after surgery

Secondary outcomes (16)
  1. Number of patients affected by minor complications after surgery, according to underlying disease

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: First week after surgery

  2. Number of patients with cardiovascular diseases affected by minor complications after surgery

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: 90 days after surgery

  3. Number of patients with cardiovascular diseases affected by minor complications after surgery

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: 1 year after surgery

  4. Number of patients with cardiovascular diseases affected by major complications after surgery

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: First week after surgery

  5. Number of patients with cardiovascular diseases affected by major complications after surgery

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: 90 days after surgery

  6. Number of patients with cardiovascular diseases affected by major complications after surgery

    Underlying diseases group: cardiovascular, neurological, rheumatic, psychiatric, neoplasic.

    Measured: 1 year after surgery

  7. Number of patients undergoing anticoagulant treatment with minor complications

    Previous acenocoumarol treatment

    Measured: First week after surgery

  8. Number of patients undergoing anticoagulant treatment with major complications

    Previous acenocoumarol treatment

    Measured: First week after surgery

  9. Number of patients undergoing anticoagulant treatment with minor complications

    Previous acenocoumarol treatment

    Measured: 90 days after surgery

  10. Number of patients undergoing anticoagulant treatment with major complications

    Previous acenocoumarol treatment

    Measured: 90 days after surgery

  11. Number of patients undergoing antiplatelet treatment with minor complications

    Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel

    Measured: First week after surgery

  12. Number of patients undergoing antiplatelet treatment with major complications

    Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel

    Measured: First week after surgery

  13. Number of patients undergoing antiplatelet treatment with minor complications

    Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel

    Measured: 90 days after surgery

  14. Number of patients undergoing antiplatelet treatment with major complications

    Previous Acetylsalicylic acid (Aspirin), triflusal, ticlopidine, clopidogrel or prasugrel

    Measured: 90 days after surgery

  15. Transfusion rates according to the preoperative ASA group

    Number of transfusion requirement.

    Measured: 1 week after surgery

  16. Length of hospital stay according to the preoperative ASA group

    Length from the surgical intervention according to ASA risk

    Measured: 1 week after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2017
  2. Study start25 Jul 2017
  3. Primary completion31 Aug 2017 (estimated)
  4. Study completion31 Aug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03243409
Sponsor's protocol ID
IIBSP-HUM-2017-51
Status last verified
Aug 2017
First submitted
31 Jul 2017
Last updated
9 Aug 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ferrel JR, Trinh TQ, Fischer RA. Reverse total shoulder arthroplasty versus hemiarthroplasty for proximal humeral fractures: a systematic review. J Orthop Trauma. 2015 Jan;29(1):60-8. doi: 10.1097/BOT.0000000000000224.

    PubMed 25186842
  • Boileau P, Winter M, Cikes A, Han Y, Carles M, Walch G, Schwartz DG. Can surgeons predict what makes a good hemiarthroplasty for fracture? J Shoulder Elbow Surg. 2013 Nov;22(11):1495-506. doi: 10.1016/j.jse.2013.04.018. Epub 2013 Jul 5.

    PubMed 23834993
  • Bufquin T, Hersan A, Hubert L, Massin P. Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up. J Bone Joint Surg Br. 2007 Apr;89(4):516-20. doi: 10.1302/0301-620X.89B4.18435.

    PubMed 17463122
  • Stanbury SJ, Voloshin I. Reverse shoulder arthroplasty for acute proximal humeral fractures in the geriatric patient: a review of the literature. Geriatr Orthop Surg Rehabil. 2011 Sep;2(5-6):181-6. doi: 10.1177/2151458511420140.

    PubMed 23569688
  • Cuff DJ, Pupello DR. Comparison of hemiarthroplasty and reverse shoulder arthroplasty for the treatment of proximal humeral fractures in elderly patients. J Bone Joint Surg Am. 2013 Nov 20;95(22):2050-5. doi: 10.2106/JBJS.L.01637.

    PubMed 24257664
  • Boyle MJ, Youn SM, Frampton CM, Ball CM. Functional outcomes of reverse shoulder arthroplasty compared with hemiarthroplasty for acute proximal humeral fractures. J Shoulder Elbow Surg. 2013 Jan;22(1):32-7. doi: 10.1016/j.jse.2012.03.006. Epub 2012 May 29.

    PubMed 22652065
  • Jones KJ, Dines DM, Gulotta L, Dines JS. Management of proximal humerus fractures utilizing reverse total shoulder arthroplasty. Curr Rev Musculoskelet Med. 2013 Mar;6(1):63-70. doi: 10.1007/s12178-013-9155-1.

    PubMed 23334846
  • Lenarz C, Shishani Y, McCrum C, Nowinski RJ, Edwards TB, Gobezie R. Is reverse shoulder arthroplasty appropriate for the treatment of fractures in the older patient? Early observations. Clin Orthop Relat Res. 2011 Dec;469(12):3324-31. doi: 10.1007/s11999-011-2055-z.

    PubMed 21879403
  • Chalmers PN, Slikker W 3rd, Mall NA, Gupta AK, Rahman Z, Enriquez D, Nicholson GP. Author reply: reverse total shoulder for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. J Shoulder Elbow Surg. 2014 Sep;23(9):e222. doi: 10.1016/j.jse.2014.05.014. Epub 2014 Jul 24. No abstract available.

    PubMed 25066822
  • Acevedo DC, Vanbeek C, Lazarus MD, Williams GR, Abboud JA. Reverse shoulder arthroplasty for proximal humeral fractures: update on indications, technique, and results. J Shoulder Elbow Surg. 2014 Feb;23(2):279-89. doi: 10.1016/j.jse.2013.10.003.

    PubMed 24418780
  • Mata-Fink A, Meinke M, Jones C, Kim B, Bell JE. Reverse shoulder arthroplasty for treatment of proximal humeral fractures in older adults: a systematic review. J Shoulder Elbow Surg. 2013 Dec;22(12):1737-48. doi: 10.1016/j.jse.2013.08.021.

    PubMed 24246529
  • Sebastia-Forcada E, Cebrian-Gomez R, Lizaur-Utrilla A, Gil-Guillen V. Reverse shoulder arthroplasty versus hemiarthroplasty for acute proximal humeral fractures. A blinded, randomized, controlled, prospective study. J Shoulder Elbow Surg. 2014 Oct;23(10):1419-26. doi: 10.1016/j.jse.2014.06.035. Epub 2014 Jul 30.

    PubMed 25086490
  • Wall B, Walch G. Reverse shoulder arthroplasty for the treatment of proximal humeral fractures. Hand Clin. 2007 Nov;23(4):425-30, v-vi. doi: 10.1016/j.hcl.2007.08.002.

    PubMed 18054669

Questions about this trial

What is this clinical trial studying?

An observational study of Proximal Humeral Fracture, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Laura Noguera Alonso (+34660708399, lnoguera@santpau.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients affected by minor complications according to preoperative risk (ASA) in reversed shoulder arthroplasties due to complex proximal humeral fractures. (time frame: First week after surgery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03243409, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in